Osamu Kaminuma

Osamu Kaminuma

Auto-generated profile, based on publicly available information

Osamu Kaminuma

Allergy and Immunology Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
OKO. Kaminuma
O. Kaminuma
TOT. Ohtomo
T. Ohtomo
AMA. Mori
A. Mori
DNDaisuke Nagakubo
Daisuke Nagakubo
KHK. Hieshima
K. Hieshima
THT. Hiroi
T. Hiroi

11 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TNTomoe Nishimura
Tomoe Nishimura
OKOsamu Kaminuma
Osamu Kaminuma
MSMayumi Saeki
Mayumi Saeki
NKNoriko Kitamura
Noriko Kitamura
KMKunie Matsuoka
Kunie Matsuoka
THTakachika Hiroi
Takachika Hiroi
Nasal hyperresponsiveness (NHR) is a characteristic feature of allergic rhinitis (AR); however, the pathogenesis of NHR is not fully understood. In this study, during the establishment of an experimental AR model using ovalbumin-immunized and -challenged mice, augmentation of the sneezing reaction in response to nonspecific proteins as well as a chemical stimulant was detected. Whether NHR is independent of mast cells and eosinophils was determined by using mast cell- and eosinophil-deficient mice. NHR was suppressed by treatment with anti-CD4 antibody, suggesting the pivotal contribution of CD4+ T cells. Furthermore, antigen challenge to mice to which in vitro-differentiated Th1, Th2, and Th17 cells but not naïve CD4+ T cells had been adoptively transferred led to the development of equivalent NHR. Since antigen-specific IgE and IgG were not produced in these mice and since antigen-specific IgE-transgenic mice did not develop NHR even upon antigen challenge, humoral immunity would be dispensable for NHR. CD4+ T cells play a crucial role in the pathogenesis of AR via induction of NHR, independent of IgE-, mast cell-, and eosinophil-mediated responses.

1 October 2005 in Immunology & Cell Biology
Verified
Journal Article
Closed access
PDF file
NKNoriko Kitamura
Noriko Kitamura
OKOsamu Kaminuma
Osamu Kaminuma
AMAkio Mori
Akio Mori
THTomomi Hashimoto
Tomomi Hashimoto
FKFujiko Kitamura
Fujiko Kitamura
SMShoichiro Miyatake
Shoichiro Miyatake

1 September 2011 in Expert Review of Vaccines
Verified
Journal Article
Closed access
THTakachika Hiroi
Takachika Hiroi
OKOsamu Kaminuma
Osamu Kaminuma
FTFumio Takaiwa
Fumio Takaiwa

1 May 2012 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
OKOsamu Kaminuma
Osamu Kaminuma
NKNoriko Kitamura
Noriko Kitamura
AMAkio Mori
Akio Mori
HTHideki Tatsumi
Hideki Tatsumi
SNSoichi Nemoto
Soichi Nemoto
THTakachika Hiroi
Takachika Hiroi
Background: The NFAT family transcription factors play crucial roles in T cell functions. Recently, NFAT has been implicated in the production of an inflammatory cytokine, IL-17A; however, functional differences among NFAT members in IL-17A synthesis have not been elucidated. In this study, the relative contribution of NFAT1 and NFAT2 to IL-17A expression in human T cells was investigated. Methods: NFAT1 and NFAT2 were introduced in human cord blood CD4+ T cells by a lentiviral transduction system. Then, the expression of IL-17A mRNA was determined by quantitative real-time RT-PCR. The transient effects of NFAT1 and NFAT2 on IL-17A expression in Jurkat-Tag cells were also investigated. Results: Stimulation-induced expression of IL-17A in human CD4+ T cells was augmented by the introduction of NFAT1 and more vigorously, NFAT2. IL-17A expression in Jurkat-Tag cells was also enhanced by NFAT1, whereas it was not affected by NFAT2. Conclusion: NFAT1 and NFAT2 facilitated IL-17A expression in human T cells, though distinct mechanisms might be involved in these effects.

30 March 2016 in Current Immunology Reviews
Verified
Journal Article
Closed access
PDF file
MSMayumi Saeki
Mayumi Saeki
TNTomoe Nishimura
Tomoe Nishimura
OKOsamu Kaminuma
Osamu Kaminuma
HOHiroshi Ohtsu
Hiroshi Ohtsu
AMAkio Mori
Akio Mori
THTakachika Hiroi
Takachika Hiroi
Histamine, a prominent mediator of the symptoms and pathogenesis of allergic diseases, is produced not only by mast cells and basophils via the classical degranulation process but also by other immune cells including T cells via a neosynthesis process. Interestingly, T cells produce and are affected by histamine. Various T cell functions are also regulated by histamine via H1, H2, and H4 receptors. We recently demonstrated that T cells induce massive allergic inflammation without assistance from the immunoglobulin E (IgE)/mast cell-dependent pathway, and histamine may be involved in the development of allergic diseases via the functional modulation of and production by T cells. Based on these reports, we propose a new role of histamine and T cells in allergic diseases that differs from the established paradigm. Aside from our recent study showing the downregulation of regulatory T (Treg) cells by histamine via H1R and H4R in a murine allergic dermatitis model, the detailed roles of histamine and T cells in histamine production, expression of histamine receptors, and histamine-mediated activity for a series of T cell subsets remain to be elucidated.